It's an interesting bio.
The nearest competitor, NA1 (NoNo) is currently on Phase 3 trial (expected to completed December 2020).
But AGN's is still pre-clinical.
It takes NoNo 8 years from Phase 1 to Phase 3.
I think it's a long way to go.
ARGENICA THERAPEUTICS LIMITED IPO Analysis, page-2
-
- There are more pages in this discussion • 89 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AGN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
75.0¢ |
Change
-0.040(5.06%) |
Mkt cap ! $95.34M | |||
| Open | High | Low | Value | Volume |
| 79.5¢ | 79.5¢ | 74.5¢ | $140.5K | 182.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 700 | 74.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 75.5¢ | 1476 | 1 |
View Market Depth
| Last trade - 15.51pm 20/09/2024 (20 minute delay) ? |
| AGN (ASX) Chart |